Impaired cardiovascular response to standing in chronic fatigue syndrome.
Hollingsworth, Kieren G, Jones, David E J, Taylor, Roy et al. · European journal of clinical investigation · 2010 · DOI
Quick Summary
This study found that people with ME/CFS have abnormal heart function when standing up, and their heart and muscle cells struggle to produce energy efficiently. Researchers used specialized scans to measure energy metabolism in the heart and muscles, and found that about one-third of ME/CFS patients showed significant heart energy problems. When standing, ME/CFS patients had stronger heart contractions and more symptoms compared to healthy controls, suggesting their bodies are working much harder to maintain blood flow.
Why It Matters
This study provides objective biophysical evidence that ME/CFS involves cardiac energy metabolism dysfunction and abnormal cardiovascular responses to postural stress, bridging the gap between patient-reported orthostatic symptoms and measurable physiological abnormalities. The findings support orthostatic intolerance as a core feature of ME/CFS pathophysiology rather than a psychological symptom, and suggest that cardiac MR spectroscopy may be a useful diagnostic tool with good safety profile.
Observed Findings
One-third of CFS patients (4/12) had cardiac phosphocreatine/ATP ratios indicating significant cardiac energy impairment.
Cardiac and skeletal muscle bioenergetic dysfunction correlated significantly (kappa = -0.71 for PCr recovery half-time, P=0.005).
95% of CFS patients (61/64) reported orthostatic symptoms on head-up tilt versus 39% of controls (25/64; P<0.0001).
CFS patients showed significantly higher left ventricular work index (LVWI) during standing compared to controls (P=0.05).
Cardiac bioenergetic impairment correlated with reduced proton efflux rates (P<0.05), suggesting impaired muscle energy utilization.
Inferred Conclusions
Skeletal and cardiac muscle bioenergetic abnormalities are linked in ME/CFS and may represent a systemic metabolic dysfunction.
Cardiac energy metabolism impairment associates with abnormally elevated cardiac contractility on standing, suggesting the heart must work harder to maintain hemodynamics.
Hemodynamic assessment via head-up tilt testing is safe and well-tolerated in ME/CFS with high diagnostic yield for detecting orthostatic dysfunction.
Remaining Questions
Does the impaired cardiac energy metabolism precede or follow the development of ME/CFS, or is it a consequence of reduced activity?
What This Study Does Not Prove
This study does not prove that impaired cardiac energy metabolism causes ME/CFS symptoms, only that they are associated. The cross-sectional design cannot establish causality or determine whether the cardiac dysfunction is primary or secondary to another underlying process. The small sample size for MRS analysis (n=12) limits generalizability, and the study does not distinguish whether abnormal LVWI responses are compensatory or pathological.
Tags
Symptom:Orthostatic IntoleranceFatigue
Biomarker:MetabolomicsBlood Biomarker
Method Flag:Weak Case DefinitionSmall SampleStrong Phenotyping
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
What proportion of ME/CFS patients have cardiac bioenergetic dysfunction, and does severity correlate with clinical outcomes or prognosis?
Are the elevated LVWI responses on standing a compensatory mechanism that temporarily maintains blood flow, or do they contribute to symptom burden?
Do interventions targeting cardiac energy metabolism or cardiovascular autonomic function improve symptoms in patients with documented bioenergetic impairment?